University of Cambridge > Talks.cam > Isaac Newton Institute Seminar Series > Jointly optimal design of Phase II and Phase III clinical trials: an over-arching approach

  Browse A-Z

Log in

University Account External (via Google)

🔐 Log In

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

ℹī¸ Information

Jointly optimal design of Phase II and Phase III clinical trials: an over-arching approach

Download to your calendar using vCal

If you have a question about this talk, please contact Mustapha Amrani .

Design and Analysis of Experiments

We consider the joint design of Phase II and Phase III trials. We propose a decision theoretic formulation with a gain function arising from a positive Phase III outcome and costs for sampling and for time taken to reach a positive conclusion. With a prior for the dose response model and a risk curve for the probability that doses fail on safety grounds, the challenge is to optimise the design for comparing doses in Phase II, the choice of dose or doses to take forward to Phase III , and the Phase III design. We shall show it is computationally feasible to tackle this problem and discuss possible generalisations from an initial, simple formulation.

This talk is part of the Isaac Newton Institute Seminar Series series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

Newnham Terrace Seminar Room, Darwin College Collusion Seminars CaMedia

Other talks

Title TBC Discussion II Tea and Coffee Break "That's History. That's Truth. I Seen It Myself": T'tc~tsa (Wailaki) and the Enslavement of California Native Americans. Title to be confirmed Reproducibility In Astrophysical Simulations: The AGORA Initiative and a 14-Year Human Experiment (In Memory of Joel Primack)
 

Š 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity